Concerning new research has uncovered that obesity may be linked to a greater number of cancers than previously understood, with weight loss potentially offering one of the most powerful protections against these diseases. The findings suggest that the established connections between excess body weight and cancer incidence have been significantly underestimated in Britain and beyond.
Alarming Statistics and Underestimated Risks
Currently, more than 18,000 preventable cancer cases in Britain are associated with obesity, positioning it as the second leading cause of the disease after smoking. In England alone, approximately 28 percent of adults are classified as obese by the NHS, defined by a Body Mass Index (BMI) exceeding 30. An additional 36 percent are estimated to be overweight, with a BMI over 25.
However, fresh analysis from a German research team, published in the journal JAMA Oncology, indicates these figures linking obesity to cancer may have been strongly underestimated. The study examined data from the UK, Germany, and Sweden to explore the relationship between the so-called obesity epidemic and cancer rates.
Detailed Findings from International Data
The researchers analysed a cohort of 458,660 individuals from the UK Biobank, a repository containing comprehensive medical information from volunteers. Their investigation revealed that obesity was connected to 7.2 percent of gastrointestinal cancers diagnosed within four years following weight measurement. Strikingly, this proportion increased to 17.7 percent when considering cancers diagnosed more than four years later.
This discrepancy suggests the link between obesity and cancer in Britain may be substantially underreported, as individuals with undiagnosed cancer often experience weight loss, thereby masking the true association.
International Comparisons and Specific Risks
In Germany, the study of over 10,000 participants found that being overweight for extended periods was 55 percent more strongly linked to bowel cancer risk than BMI alone. The researchers noted, however, that this pattern may not apply uniformly across all cancer types, as different cancers may respond variably to long-term weight exposure.
Swedish data from more than 339,000 individuals uncovered that men with larger waist sizes faced a 25 percent higher risk of obesity-related cancers, compared to a 19 percent increase associated with BMI. This indicates that abdominal fat, rather than overall weight, may serve as a superior predictor of cancer risk in men.
Reevaluating Risk Thresholds and Prevention Strategies
Overall, the research team discovered that cancer risk begins to escalate even below the conventional BMI threshold of 25, implying current overweight classifications may overlook individuals at potential risk. The authors argue that obesity control has been underexploited as a powerful cancer prevention strategy and have proposed a new framework named PLUS to enhance risk assessment.
The PLUS framework aims to account for weight loss preceding diagnosis, consider lifetime weight history, incorporate waist circumference alongside BMI, and acknowledge that risk can initiate below existing thresholds. The researchers stated, "The PLUS framework discloses a much stronger cancer-preventive potential of obesity prevention and control than previously established."
They emphasised, "Given the ongoing obesity epidemic and its links to numerous adverse health outcomes, such as diabetes and cardiovascular disease, this underlines the urgency and expected rewards of enhanced efforts toward prevention and treatment of overweight and obesity." The authors also called for obesity prevention measures to be systematically integrated into public health systems.
It is important to note that much of this study was observational, meaning the researchers cannot definitively prove cause and effect. Nonetheless, the findings highlight a critical need for renewed focus on weight management as a cornerstone of cancer prevention efforts.
